kylmäablatiota

Kylmäablaatio, also known as cryoablation or cryotherapy, is a medical procedure used to destroy abnormal or diseased tissue. It involves applying extreme cold to the target area, causing ice crystals to form within and around the cells. This ice formation disrupts the cell membranes and blood supply, leading to cell death.

The procedure is minimally invasive and is typically performed using a thin, hollow probe called a cryoprobe. The probe is inserted into or near the abnormal tissue, and a refrigerant, such as argon gas or nitrogen, is passed through it to lower its temperature significantly. The precise temperature and duration of the freezing are carefully controlled by the physician to ensure effective destruction of the target cells while minimizing damage to surrounding healthy tissue.

Kylmäablaatio has a variety of applications in medicine. It is commonly used to treat certain types of tumors, including kidney cancer and liver cancer. It can also be employed to address cardiac arrhythmias by ablating abnormal heart tissue that causes irregular heartbeats. In dermatology, it is used to remove skin lesions, warts, and precancerous growths. The technique is also explored for treating benign conditions like uterine fibroids. After the procedure, the destroyed tissue is gradually absorbed by the body or eliminated. The recovery time varies depending on the treated condition and location, but it is generally shorter than traditional surgical interventions.